Clinical Trials Logo

Clinical Trial Summary

This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo group will receive same amount of normal saline after spinal anesthesia prior to skin incision. Postoperative outcomes measures are total opioid consumption and pain scores for 24 hrs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Non Elective Cesarean Section and Ketamine Analgesia

NCT number NCT03450499
Study type Interventional
Source B.P. Koirala Institute of Health Sciences
Contact
Status Completed
Phase Phase 4
Start date April 1, 2018
Completion date March 7, 2019